Skip to content
Advanced Consensus
For physicians & institutions · Clinically interpreted

Advanced Consensus

Advanced molecular diagnostics, read with clinical judgment.

We coordinate advanced genetic testing through international reference labs — interpreted locally.

Advanced Consensus is the send-out testing partner for physicians and institutions across Jordan and the MENA region. We match each clinical question to the right assay at an international reference laboratory, manage the logistics, and return results read with clinical judgment — so you act on an answer, not just a data file.

Physician-guided ordering
International reference labs
Local clinical interpretation
Managed send-out logistics

AC pathway

From clinical question to report

Advanced Consensus

1. Clinical question

Clarify indication and test fit

2. Specimen ready

Confirm tube, tissue, and forms

3. Send-out managed

Coordinate logistics and tracking

4. Result reviewed

Clinically framed reporting support

Clinically organized menu

Browse by indication, not by vendor catalog.

NIPTSolid tumor NGSLiquid biopsyWES / WGSCMAPGx

Partner laboratory network

Testing performed by accredited international reference labs

3

Reference labs

40+

Clinical tests

8

Specialties

3billion

Seoul, Korea

Rare Disease · WES / WGS · Oncology · NIPT

CAPCLIAISO/IEC 27001
GC Genome

Yongin-si, Korea

NIPT · Hematology · Solid Tumor · PGx · Wellness

CAPMFDSKIGTE Grade A
EDGC

Incheon, Korea

Chromosomal Microarray · Reproductive Genetics

CAPCLIA

Accreditations are held by the reference laboratories listed above, not by Advanced Consensus. AC serves as the local clinical coordination and interpretation partner.

Who we serve

Designed around the teams who act on the result

Four distinct pathways — physicians, institutions, specialist centres, and patients — each leading to the right next step.

Clinical ordering support

Physicians

Choose the appropriate test for the indication, specimen, and clinical decision point — with guidance before ordering and interpretation after reporting.

  • Oncology and hematology
  • Hereditary risk
  • Rare disease and reproductive genetics

Managed send-out program

Hospitals & Laboratories

Expand your advanced testing menu without building every assay in-house. AC can support workflows, logistics, reporting, and clinician communication.

  • Client-specific test menus
  • Operational coordination
  • Partnership-ready workflows

Physician-guided testing

Patients & Families

Genetic testing is most useful when connected to professional medical advice. AC supports patients through their treating physicians and institutions.

  • No self-diagnosis
  • Consent-aware process
  • Results used in clinical context

Specialist pathways

IVF & Oncology Centres

IVF centres and oncology practices can access targeted testing pathways — reproductive genetics, preimplantation, tumour profiling — through a managed send-out relationship.

  • Reproductive genetics & CMA
  • Solid tumour & hematologic panels
  • Dedicated account coordination

How it works

A simpler path from question to report

The service is designed to reduce ordering friction while preserving clinical rigor and patient safety.
01

Clinical question

Share the indication, diagnosis, prior testing, and specimen availability.

02

Test selection

We confirm the most suitable test, sample type, request form, and consent needs.

03

Sample logistics

The pathway is coordinated locally, including collection requirements and shipment handling.

04

Laboratory analysis

Testing is performed through the selected reference-lab or specialized molecular pathway.

05

Report & support

Results are framed for clinical use, with follow-up discussion when interpretation is complex.

For complex oncology, hereditary, or rare-disease cases, start with the clinical question rather than the assay name. AC can help map the case to the right testing route.

Start a Test Request

Why Advanced Consensus

The value is not only access — it is judgment

Many advanced tests can be ordered online. The difficult part is selecting the right assay, obtaining a suitable specimen, understanding limitations, and translating results into clinical next steps.

Built for clinical responsibility

AC positions testing as a physician-guided clinical service. That protects patients, supports institutions, and improves the usefulness of molecular results.

Expert clinical interpretation

Results are reviewed with molecular pathology and clinical genetics expertise, so clinicians receive context rather than isolated data.

Curated, relevant menu

The menu prioritizes testing with practical clinical use for regional physicians, hospitals, and laboratories.

Global access, local accountability

AC handles cross-border complexity so specialized testing can feel like a local service with a reachable team.

Physician-centered workflow

The process supports appropriate ordering, consent-aware communication, and clear next steps after reporting.

Quality, consent & data protection

A safer front end for sensitive genetic information

Genetic and molecular data can affect diagnosis, treatment, reproductive decisions, and family members. AC's model keeps sensitive information within appropriate clinical channels while making advanced testing practically accessible.

Appropriate ordering

Testing should be tied to a clinical indication and ordered through a qualified healthcare professional.

Consent-aware workflows

Genetic testing requires attention to consent, family implications, and downstream communication.

Confidential handling

Reports and inquiry workflows are designed to avoid unnecessary patient-identifiable data exposure.

Responsible interpretation

Results are presented as clinical support, not a substitute for medical judgment or counseling.

Clinical leadership

Every report carries a name

The difference between test access and clinical judgment is a named specialist who takes responsibility for how each result is read.
{{PLACEHOLDER: medical director headshot — needs Omar Issa}}

Omar Issa

MD — Medical Director, Advanced Consensus

Medical Director, Advanced Consensus

View full profile

Every report that leaves Advanced Consensus has been reviewed by Dr. Issa — I take personal responsibility for how each result is interpreted and communicated.

Clinical responsibility for report review and interpretation rests with a named specialist — not an anonymous service.

In their words

What physicians and partners say

Feedback from the clinicians and institutions who order through Advanced Consensus.
Advanced Consensus has become a trusted partner in complex molecular and genetic testing. Their team does more than coordinate a test — they help us understand which assay is most appropriate, what the result means clinically, and how it may affect patient management. The clarity of their interpretation and the speed of communication have been valuable for our clinical decision-making.
Arkan — Consultant Physician, Oncology
When I received my genetic test result, I was worried and unsure what it meant for me and my family. Advanced Consensus provided a clear explanation in language I could understand, and helped guide the next steps with my physician. The process gave me reassurance, clarity, and confidence that the result was being handled carefully.
Sarah — Patient
Advanced Consensus offers the kind of specialised molecular diagnostics support that hospitals need today. Their model gives clinicians access to advanced international testing while maintaining local medical guidance, clear reporting, and professional coordination. They have helped us expand our precision medicine capabilities without compromising quality or patient care.
Fawzi — Hospital Chief Executive Officer

Get in touch

Start with the clinical question

Whether you need a specific assay, a send-out pathway, or help choosing between testing options, AC can help translate the case into the right next step.

Suite 403, 133 Madina Munawara St, Amman, Jordan

+962 791 707 606 info@advancedconsensus.comMessage us on WhatsApp

For website inquiries, do not include patient names, medical record numbers (MRNs), national IDs, dates of birth, or identifiable reports or documents. Secure document exchange should happen through approved clinical channels.

Prefer to talk it through first?

Request a 15-minute case discussion before you order.

  • 15 minutes — focused on one clinical question.
  • By video or phone, at a time that suits your clinic.
  • No obligation, and no patient-identifiable details needed to book.
Request a case discussion →

Secure document exchange should happen through approved clinical channels.